A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. - Levander XA; Carmody T; Cook RR; Potter JS; Trivedi MH; Korthuis PT; Shoptaw S (Addiction (Abingdon, England), 2023)